vTv Therapeutics (VTVT) Long-Term Investments (2017 - 2023)

vTv Therapeutics has disclosed Long-Term Investments across 7 years of filings, most recently posting $4.4 million for Q3 2023.

• Long-Term Investments for Q3 2023 came in at $4.4 million, down 28.96% year-over-year; the trailing twelve-month figure through Sep 2023 was $4.4 million (down 28.96% YoY), and the FY2022 annual result was $5.6 million, down 39.08% from the prior year.
• Long-Term Investments came in at $4.4 million for Q3 2023 at vTv Therapeutics, down from $8.0 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $9.6 million in Q2 2021 to a low of $2.5 million in Q1 2019.
• The 5-year median for Long-Term Investments is $5.8 million (2022), against an average of $5.4 million.
• Across the five-year window, Long-Term Investments surged 287.98% in 2021 and tumbled 40.01% in 2022, its largest moves.
• vTv Therapeutics' Long-Term Investments stood at $2.5 million in 2019, then jumped by 171.17% to $6.7 million in 2020, then jumped by 36.4% to $9.2 million in 2021, then plunged by 39.08% to $5.6 million in 2022, then declined by 21.49% to $4.4 million in 2023.
• The last three Long-Term Investments figures came in at $4.4 million (Q3 2023), $8.0 million (Q2 2023), and $7.7 million (Q1 2023), per Business Quant data.